BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Regulus Therapeutics, Inc. 

1896 Rutherford Road

Carlsbad  California  92008-7208  U.S.A.
Phone: 888-734-8587 Fax: n/a


SEARCH JOBS





Segment
Start Up





 Company News
Regulus Therapeutics, Inc. (RGLS) To Present At The 26th Annual Piper Jaffray Healthcare Conference And Genetic Rx Conference 12/1/2014 3:52:00 PM
Regulus Therapeutics, Inc. (RGLS) And Sanofi (SAN.PA) Present New Data Enhancing The Preclinical Profile Of RG-012, An Anti-Mir Targeting Microrna-21 For The Treatment Of Renal Dysfunction In Alport Syndrome Patients, At ASN's Kidney Week 2014 Meeting 11/17/2014 11:28:11 AM
Regulus Therapeutics, Inc. (RGLS) To Present At The Credit Suisse Healthcare Conference 11/7/2014 7:47:00 AM
Regulus Therapeutics, Inc. (RGLS) To Present At The Credit Suisse Healthcare Conference 11/6/2014 11:50:02 AM
Regulus Therapeutics, Inc. (RGLS) Reports Third Quarter 2014 Financial Results And Recent Highlights 11/6/2014 7:33:17 AM
Regulus Therapeutics, Inc. (RGLS) Announces Closing of Public Offering Of $103.5M Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares 11/4/2014 7:28:44 AM
Regulus Therapeutics, Inc. (RGLS) Announces Timing For Third Quarter 2014 Financial Results Webcast And Conference Call 10/31/2014 7:49:52 AM
Regulus Therapeutics, Inc. (RGLS) Announces Pricing Of Public Offering Of Common Stock 10/29/2014 7:50:07 AM
Regulus Therapeutics, Inc. (RGLS) Announces Commencement Of Public Offering Of Common Stock 10/28/2014 7:27:40 AM
Regulus Therapeutics, Inc. (RGLS) Gets Seat At Hepatitis C Table With Impressive Phase 1 Results 10/22/2014 8:22:52 AM
12345678910...